Describe bacterial conjunctivitis, including its etiology, clinical presentation, diagnosis, and treatment.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bacterial Conjunctivitis Overview

Bacterial conjunctivitis is a common, typically self-limited infection characterized by purulent or mucopurulent discharge that mats the eyelids (especially on waking), bilateral bulbar conjunctival injection, and a foreign body sensation, most commonly caused by Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. 1, 2

Etiology

Common Pathogens by Age Group

Adults:

  • Staphylococcus aureus (most common) 3, 4
  • Staphylococcus epidermidis 3
  • Streptococcus pneumoniae 3, 4
  • Moraxella species 3

Children:

  • Haemophilus influenzae (44.8% of cases, most prevalent) 5, 6, 7
  • Streptococcus pneumoniae (30.6% of cases) 5, 6, 7
  • Moraxella catarrhalis 5, 6, 7
  • Staphylococcus aureus (more prevalent in children aged 7-14 years) 5

Neonates:

  • Staphylococcus aureus (most common) 6
  • Chlamydia trachomatis (manifests 5-19 days after birth, associated with pneumonia in 50% of cases) 2, 8
  • Neisseria gonorrhoeae (manifests within 1-7 days after birth, medical emergency) 1, 2

Special Pathogens Requiring Immediate Recognition

Gonococcal conjunctivitis presents with marked eyelid edema, copious purulent discharge, and preauricular lymphadenopathy—this is a medical emergency that can cause corneal perforation within 24-48 hours and requires immediate systemic antibiotics in addition to topical therapy. 1, 2, 8

Chlamydial conjunctivitis presents with follicular inflammation on the bulbar conjunctiva and semilunar fold, requiring systemic antibiotics because topical agents alone are insufficient. 2, 8

Clinical Presentation

Cardinal Signs

  • Discharge: Bilateral green or yellow purulent/mucopurulent discharge that mats eyelids, particularly on waking 2, 6
  • Injection: Bulbar conjunctival injection (red eye) 1, 2
  • Symptoms: Foreign body sensation, sticky eyes 6
  • Laterality: Usually bilateral, though may initially affect one eye before spreading 1, 2

Associated Risk Factors

Children:

  • Contact with infected individuals 1
  • Concomitant bacterial otitis media, sinusitis, or pharyngitis 1
  • Nasopharyngeal bacterial colonization 1
  • Oculogenital spread (consider sexual abuse) 1, 8

Adults:

  • Contact with infected individuals 1
  • Oculogenital spread 1
  • Unhygienic living conditions 1
  • Infection or abnormality of adnexal structures 1
  • Lid malposition 1
  • Severe tear deficiency 1
  • Immunosuppression 1
  • Trauma 1

Diagnosis

Clinical Diagnosis Algorithm

Step 1: Identify purulent discharge pattern

  • Bilateral green/yellow discharge matting eyelids on waking strongly suggests bacterial etiology 2, 6

Step 2: Examine for red-flag features requiring immediate referral

  • Severe purulent discharge with marked eyelid edema → suspect gonococcal conjunctivitis 2, 8
  • Follicles on bulbar conjunctiva and semilunar fold → suspect chlamydial conjunctivitis 2
  • Any purulent conjunctivitis in a neonate → emergency until gonococcal/chlamydial causes ruled out 2, 8

Step 3: Perform fluorescein staining

  • Always examine the cornea with fluorescein staining in any case of purulent conjunctivitis to detect early corneal involvement 2, 8
  • Gonococcal infection often begins with superior corneal infiltration or ulceration 8

Step 4: Determine need for microbiological testing

  • Cultures are unnecessary for typical uncomplicated cases in immunocompetent patients 6
  • Cultures are indicated for persistent or severe cases, immunocompromised patients, or when gonococcal/chlamydial infection is suspected 4

Laboratory Diagnosis (When Indicated)

Gram stain of conjunctival scrapings:

  • Provides rapid prediction of pathogen in 93% of bacterial cases (51 of 55 cases) 7
  • Shows neutrophilia in bacterial infections 7

Giemsa stain of conjunctival scrapings:

  • Provides etiologic information in 96% of cases (81 of 84 cases) 7
  • Neutrophilia indicates bacterial infection 7
  • Lymphocytosis indicates viral infection 7
  • Eosinophilia indicates allergic disease 7

Culture technique:

  • Separately culture specimens from lids and conjunctivae to distinguish normal flora from pathogens 7
  • Normal lid flora includes staphylococci, corynebacteria, and alpha-hemolytic streptococci 7

Treatment

First-Line Management for Uncomplicated Cases

Delayed antibiotic prescribing is preferred for most uncomplicated cases because the majority resolve spontaneously within 1-2 weeks—provide a prescription but advise waiting 2-3 days before filling if symptoms do not improve. 2

Immediate topical antibiotic therapy is indicated when rapid resolution is desired to shorten symptom duration and facilitate earlier return to school or work. 2

Topical Antibiotic Options

Recommended agents:

  • Fluoroquinolones (e.g., ciprofloxacin) 4, 5
  • Azithromycin 4
  • Trimethoprim-polymyxin B 2
  • Aminoglycosides 2
  • Chloramphenicol 5

Evidence for efficacy:

  • Topical antibiotics increase the 7-day cure rate by an absolute risk difference of 0.09 compared to placebo 2
  • They shorten disease course, reduce discomfort, prevent person-to-person transmission, and reduce reinfection rates 6

Critical Pitfall to Avoid

Do NOT routinely treat the second eye prophylactically in cases of unilateral, uncomplicated bacterial conjunctivitis—instead, educate patients on frequent handwashing to prevent transmission. 8

Special Populations Requiring Systemic Therapy

Gonococcal conjunctivitis:

  • Requires immediate systemic antibiotic treatment in addition to topical therapy 2, 8
  • Risk of corneal perforation within 24-48 hours 2, 8
  • Neonates at risk of septicemia, meningitis, and death 1, 8

Chlamydial conjunctivitis:

  • Requires systemic antibiotics because topical agents alone are insufficient 2, 8
  • In neonates, up to 50% have concurrent nasopharyngeal, genital, or pulmonary infection 8
  • Highly infectious through hand contact, fomites, and flies 8

Natural History and Prognosis

Typical Course

  • Mild bacterial conjunctivitis is self-limited in adults, resolving within 1-2 weeks without treatment 1, 2
  • With topical antibiotics, symptom duration is shortened and clinical remission is modestly improved 2, 6

Potential Complications

In children:

  • Rare but possible complications include corneal infection 1
  • May be associated with pharyngitis, otitis media, or meningitis 1

In neonates with gonococcal infection:

  • Corneal scarring 1
  • Corneal perforation 1
  • Septicemia with arthritis 1
  • Meningitis 1

In neonates with chlamydial infection:

  • Corneal scarring 1
  • Pneumonia (in 50% of cases) 2, 8

Prevention and Infection Control

Patient Education

  • Frequent handwashing to prevent transmission to the second eye 8
  • Avoid sharing towels, bedding, and cosmetics 8
  • Maintain proper hygiene, especially after touching eyes or face 9

Screening and Prevention

  • Screening and treating pregnant women is an effective prevention strategy by reducing perinatal transmission of gonococcal and chlamydial infections 4

Antibiotic Resistance Considerations

Increasing resistance patterns:

  • Streptococcus pneumoniae shows the greatest level of resistance to antibiotics used in eye drops and ophthalmic ointments 5
  • Rising antibiotic resistance may necessitate tailored therapy based on antibiotic susceptibility profiles 4
  • Widespread antibiotic use and insufficient bactericidal concentrations at the infection site contribute to resistance development 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Critical Diagnoses in Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Research

[Bacterial Conjunctivitis: Current Aspects of Diagnosis and Therapy].

Klinische Monatsblatter fur Augenheilkunde, 2024

Research

[Bacterial conjunctivitis: most prevalent pathogens and their antibiotic sensitivity].

Anales de pediatria (Barcelona, Spain : 2003), 2004

Research

Bacterial Conjunctivitis in Childhood: Etiology, Clinical Manifestations, Diagnosis, and Management.

Recent patents on inflammation & allergy drug discovery, 2018

Research

Acute conjunctivitis in childhood.

The Journal of pediatrics, 1993

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Isolation Period for Acute Follicular Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.